MTI Ltd. (TYO:9438)
846.00
-5.00 (-0.59%)
May 22, 2025, 3:30 PM JST
MTI Ltd. Revenue
MTI Ltd. had revenue of 7.61B JPY in the quarter ending March 31, 2025, with 10.47% growth. This brings the company's revenue in the last twelve months to 29.04B, up 8.82% year-over-year. In the fiscal year ending September 30, 2024, MTI Ltd. had annual revenue of 27.67B with 3.25% growth.
Revenue (ttm)
29.04B
Revenue Growth
+8.82%
P/S Ratio
1.61
Revenue / Employee
24.52M
Employees
1,184
Market Cap
46.82B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 30, 2024 | 27.67B | 871.00M | 3.25% |
Sep 30, 2023 | 26.80B | 319.00M | 1.20% |
Sep 30, 2022 | 26.48B | 736.00M | 2.86% |
Sep 30, 2021 | 25.74B | -339.00M | -1.30% |
Sep 30, 2020 | 26.08B | -1.03B | -3.80% |
Sep 30, 2019 | Pro | Pro | Pro |
Sep 30, 2018 | Pro | Pro | Pro |
Sep 30, 2017 | Pro | Pro | Pro |
Sep 30, 2016 | Pro | Pro | Pro |
Sep 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,222.12B |
Daiichi Sankyo Company | 1,886.26B |
Takeda Pharmaceutical Company | 4,581.55B |
HOYA Corporation | 869.37B |
Terumo | 1,036.17B |
Otsuka Holdings | 2,393.18B |
Astellas Pharma | 1,912.32B |
Olympus | 997.33B |